hat
Ekspè yo te rechèch entrige pa efè yo nan Oxandrolone ki fèb anpil androjèn nan relasyon ak yon efè anabolizan dwòg la. Yo pita, nan 1964, prezante dwòg la kòm yon medikaman pharmaceutique pou pwomosyon pou rejè nan misk nan moun ki gen pèdi pwa envolontè kòm byen ke yon tretman VIH / SIDA.
eng
The research experts were intrigued by the extremely weak androgenic effects of Oxandrolone in relation to the drug’s anabolic effects. They later, in 1964, introduced the drug as a pharmaceutical medication for the promotion of muscle regrowth in people with involuntary weight loss as well as an HIV/AIDS treatment.